Veracyte Stock (NASDAQ: VCYT) stock price, news, charts, stock research, profile.
Open | $19.850 |
Close | $19.900 |
Volume / Avg. | 511.680K / 659.760K |
Day Range | 19.660 - 20.070 |
52 Wk Range | 18.610 - 30.520 |
Market Cap | $1.495B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 5.48% |
Days to Cover | 5.97 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Veracyte (NASDAQ: VCYT) through any online brokerage.
Other companies in Veracyte’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and Day One Biopharmaceutical (NASDAQ:DAWN).
The latest price target for Veracyte (NASDAQ: VCYT) was reported by Goldman Sachs on Monday, April 15, 2024. The analyst firm set a price target for 28.00 expecting VCYT to rise to within 12 months (a possible 40.56% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Veracyte (NASDAQ: VCYT) is $19.92 last updated April 24, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Veracyte.
Veracyte’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Veracyte.
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.